These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11332330)

  • 21. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography.
    vom Dahl J; Herman WH; Hicks RJ; Ortiz-Alonso FJ; Lee KS; Allman KC; Wolfe ER; Kalff V; Schwaiger M
    Circulation; 1993 Aug; 88(2):395-404. PubMed ID: 8339403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.
    Iozzo P; Chareonthaitawee P; Dutka D; Betteridge DJ; Ferrannini E; Camici PG
    Diabetes; 2002 Oct; 51(10):3020-4. PubMed ID: 12351442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid.
    Mäki MT; Haaparanta M; Nuutila P; Oikonen V; Luotolahti M; Eskola O; Knuuti JM
    J Nucl Med; 1998 Aug; 39(8):1320-7. PubMed ID: 9708500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial insulin resistance in patients with syndrome X.
    Botker HE; Moller N; Schmitz O; Bagger JP; Nielsen TT
    J Clin Invest; 1997 Oct; 100(8):1919-27. PubMed ID: 9329954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
    Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
    J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial wall thickness and left ventricular geometry in hypertensives. Relationship with insulin.
    Paolisso G; Galderisi M; Tagliamonte MR; de Divitis M; Galzerano D; Petrocelli A; Gualdiero P; de Divitis O; Varricchio M
    Am J Hypertens; 1997 Nov; 10(11):1250-6. PubMed ID: 9397244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study.
    Honka MJ; Latva-Rasku A; Bucci M; Virtanen KA; Hannukainen JC; Kalliokoski KK; Nuutila P
    Eur J Endocrinol; 2018 May; 178(5):523-531. PubMed ID: 29535167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
    Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N
    J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for dissociation of insulin stimulation of blood flow and glucose uptake in human skeletal muscle: studies using [15O]H2O, [18F]fluoro-2-deoxy-D-glucose, and positron emission tomography.
    Raitakari M; Nuutila P; Ruotsalainen U; Laine H; Teräs M; Iida H; Mäkimattila S; Utriainen T; Oikonen V; Sipilä H; Haaparanta M; Solin O; Wegelius U; Knuuti J; Yki-Järvinen H
    Diabetes; 1996 Nov; 45(11):1471-7. PubMed ID: 8866549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
    Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
    J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance in essential hypertension is characterized by impaired insulin stimulation of blood flow in skeletal muscle.
    Laine H; Knuuti MJ; Ruotsalainen U; Raitakari M; Iida H; Kapanen J; Kirvelä O; Haaparanta M; Yki-Järvinen H; Nuutila P
    J Hypertens; 1998 Feb; 16(2):211-9. PubMed ID: 9535149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo-controlled FDG-PET study.
    Trolle C; Hjerrild B; Mortensen KH; Knorr S; Søndergaard HM; Christiansen JS; Gravholt CH
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):133-40. PubMed ID: 25645325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance in patients with cardiac hypertrophy.
    Paternostro G; Pagano D; Gnecchi-Ruscone T; Bonser RS; Camici PG
    Cardiovasc Res; 1999 Apr; 42(1):246-53. PubMed ID: 10435017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased blood flow but unaltered insulin sensitivity of glucose uptake in skeletal muscle of chronic smokers.
    Rönnemaa EM; Rönnemaa T; Utriainen T; Raitakari M; Laine H; Takala T; Pitkänen OP; Kirvelä O; Knuuti J; Nuutila P
    Metabolism; 1999 Feb; 48(2):239-44. PubMed ID: 10024089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise training improves insulin-stimulated myocardial glucose uptake in patients with dilated cardiomyopathy.
    Stolen KQ; Kemppainen J; Kalliokoski KK; Luotolahti M; Viljanen T; Nuutila P; Knuuti J
    J Nucl Cardiol; 2003; 10(5):447-55. PubMed ID: 14569237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.
    Bøtker HE; Böttcher M; Schmitz O; Gee A; Hansen SB; Cold GE; Nielsen TT; Gjedde A
    J Nucl Cardiol; 1997; 4(2 Pt 1):125-32. PubMed ID: 9115064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
    Turpeinen AK; Takala TO; Nuutila P; Axelin T; Luotolahti M; Haaparanta M; Bergman J; Hämäläinen H; Iida H; Mäki M; Uusitupa MI; Knuuti J
    Diabetes; 1999 Jun; 48(6):1245-50. PubMed ID: 10342811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applications of PET in diabetes research.
    Nuutila P
    Horm Metab Res; 1997 Jul; 29(7):337-9. PubMed ID: 9288564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simplified PET quantitation of myocardial glucose utilization.
    Nakagawa K; Namba H; Iyo M; Fukushi K; Irie T; Yamanouchi M; Shikama N; Himi T; Yoshida K; Masuda Y
    J Nucl Med; 1995 Nov; 36(11):2094-102. PubMed ID: 7472605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.